在商业保险受益人中,慢性鼻炎与鼻息肉治疗的支出和利用
Akash M Bhat1,2, Rodney J Schlosser1,3, Zachary M Soler1
1Division of Rhinology and Sinus Surgery, Department of Otolaryngology-Head and Neck Surgery, Medical University of South Carolina, Charleston, South Carolina, USA.
The Laryngoscope
|March 3, 2025
概括
长期鼻炎与鼻息肉 (CRSwNP) 的新疗法已获得批准,但成本差异很大. 处方药费用从7050美元到28324美元不等,自付费用从1036美元到3549美元不等.
科学领域:
- 耳鼻喉科 耳鼻喉科 耳鼻喉科
- 药物经济学 药物经济学
- 卫生政策 卫生政策
背景情况:
- 带鼻息肉的慢性鼻炎 (CRSwNP) 是一个严重的健康问题.
- 最近的食品和药物管理局 (FDA) 批准为CRSwNP提供了新的治疗选择.
- 这些新型疗法对患者和医疗保健系统的经济影响需要研究.
研究的目的:
- 分析与CRSwNP处方药相关的医疗保健支出.
- 确定使用这些新型CRSwNP疗法的患者的自费费用.
- 提供关于CRSwNP治疗的经济负担的见解.
主要方法:
- 对商业保险患者的医疗保健索赔数据的回顾性分析.
- 识别CRSwNP的处方药支出.
- 对特定CRSwNP药物的患者自费支出的计算.
主要成果:
- 针对CRSwNP的处方药费用差异很大,从EDS-FLU的7050美元到dupilumab的28324美元.
- 对CRSwNP治疗的自费费用从其他药物的1036美元到mepolizumab的3549美元不等.
- 不同的新型CRSwNP疗法之间存在显著的财务变化.
结论:
- 新型CRSwNP疗法对患者和支付人来说都带来了巨大的成本.
- 了解成本变化对于管理CRSwNP治疗的经济影响至关重要.
- 需要进一步的药物经济评估来评估这些治疗的长期价值.
更多相关视频
相关概念视频
Epistaxis
118
Epistaxis, or nosebleeds, occurs when small, swollen blood vessels in the nasal mucous membrane rupture. Typically, the anterior septum is the primary site of occurrence.
Etiology
Possible causes of this condition include high blood pressure, trauma, low humidity, upper respiratory tract infections, allergies, foreign bodies, nasal inhalation of corticosteroids or illicit drugs, excessive use of decongestant nasal sprays, facial or nasal surgery, anatomic malformation, tumors, or systemic...
Etiology
Possible causes of this condition include high blood pressure, trauma, low humidity, upper respiratory tract infections, allergies, foreign bodies, nasal inhalation of corticosteroids or illicit drugs, excessive use of decongestant nasal sprays, facial or nasal surgery, anatomic malformation, tumors, or systemic...
118
Drugs Used in Upper Respiratory Disorders: Overview
174
Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
174
Drugs Used in Lower Respiratory Disorders: Overview
334
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
334
Chronic Obstructive Pulmonary Disease-V: Nursing Management
3.5K
Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
Assessment
3.5K
COPD: Management Using Bronchodilators and Corticosteroids
170
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
170
Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K


